Baixe o app para aproveitar ainda mais
Prévia do material em texto
NOME: ESCOLA CURSO PERÍODO/ANO ESA ENFERMAGEM 4°/2023 COMPONENTE CURRICULAR DOCENTE DATA FARMACOLOGIA Jailson Machado ALUNO Tipo de atividade: Teste / Prova ( ) Problema / Situação de Estudo ( ) Prova Substitutiva ( ) Outro ( ) VALOR DA AVALIAÇÃO RESULTADO OBTIDO 10 1. CLORIDRATO DE PROMETAZINA: a) indicação: _______________________________________________________________________ _______________________________________________________________________ b) Farmacodinâmica: _______________________________________________________________________ _______________________________________________________________________ c) Diluição: _______________________________________________________________________ _______________________________________________________________________ d) Reações adversas: _______________________________________________________________________ _______________________________________________________________________ 2. BENZILPENICILINA BENZATINA: a) indicação: _______________________________________________________________________ _______________________________________________________________________ b) Farmacodinâmica: _______________________________________________________________________ _______________________________________________________________________ c) Diluição: _______________________________________________________________________ _______________________________________________________________________ d) Reações adversas: NOME: _______________________________________________________________________ _______________________________________________________________________ 3. DICLOFENACO SÓDICO: a) indicação: _______________________________________________________________________ _______________________________________________________________________ b) Farmacodinâmica: _______________________________________________________________________ _______________________________________________________________________ c) Diluição: _______________________________________________________________________ _______________________________________________________________________ d) Reações adversas: _______________________________________________________________________ _______________________________________________________________________ 4. CLORIDRATO DE TRAMADOL a) indicação: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ b) Farmacodinâmica: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ c) Diluição: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ d) Reações adversas: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ 5. CETOPROFENO NOME: a) indicação: _________________________________________________________________________ _____________________________________________________________________ b) Farmacodinâmica: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ c) Diluição: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ d) Reações adversas: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ 6. DIMENIDRINATO a) indicação: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ b) Farmacodinâmica: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ c) Diluição: _________________________________________________________________________ _____________________________________________________________________ d) Reações adversas: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ 7. METOCLOPRAMIDA a) indicação: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ NOME: b) Farmacodinâmica: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ c) Diluição: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ d) Reações adversas: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ 8. ONDANSETRONA a) indicação: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ b) Farmacodinâmica: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ c) Diluição: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ d) Reações adversas: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ 9. HIDROCORTISONA a) indicação: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ b) Farmacodinâmica: _______________________________________________________________________ NOME: _______________________________________________________________________ c) Diluição: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________d) Reações adversas: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ 10. METILPREDNISOLONA a) indicação: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ b) Farmacodinâmica: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ c) Diluição: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ d) Reações adversas: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ 11. DEXAMETASONA a) indicação: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ b) Farmacodinâmica: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ NOME: c) Diluição: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ d) Reações adversas: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ 12. DIPIRONA a) indicação: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ b) Farmacodinâmica: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ c) Diluição: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ d) Reações adversas: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ 13. MORFINA a) indicação: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ b) Farmacodinâmica: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ c) Diluição: _______________________________________________________________________ _______________________________________________________________________ NOME: _______________________________________________________________________ d) Reações adversas: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ 14. RANITIDINA a) indicação: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ b) Farmacodinâmica: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ c) Diluição: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ d) Reações adversas: _______________________________________________________________________ _______________________________________________________________________ 15. HIDRALAZINA a) indicação: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ b) Farmacodinâmica: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ c) Diluição: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ d) Reações adversas: _______________________________________________________________________ _______________________________________________________________________ NOME: _______________________________________________________________________ 16. FUROSEMIDA a) indicação: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ b) Farmacodinâmica: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ c) Diluição: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ d) Reações adversas: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ 17. ESCOPOLAMINA a) indicação: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ b) Farmacodinâmica: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ c) Diluição: _______________________________________________________________________ _______________________________________________________________________ _______________________________________________________________________ d) Reações adversas: ______________________________________________________________________________________________________________________________________________ _______________________________________________________________________ NOME:
Compartilhar